Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT
Sangamo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 18.31M | 6.44M | 7.55M | 49.41M | 356K | 481K | 2.04M | 9.4M | 6.83M | 157.96M | 27.23M | 26.46M | 29.38M | 28.23M | 27.99M | 28.56M | 27.87M | 26.28M |
Cost of Revenue | n/a | n/a | 2.13M | 2.13M | 2.57M | 2.53M | 2.98M | 11.46M | 4.26M | 3.49M | 3.34M | 3.05M | 2.88M | 2.83M | 2.76M | 62.5M | 60.09M | 56.43M |
Gross Profit | 18.31M | 6.44M | 7.55M | 47.28M | -23.87M | -2.04M | -940K | -2.07M | 2.58M | 154.47M | 23.89M | 23.41M | 26.49M | 25.4M | 25.22M | -33.94M | -32.21M | -30.15M |
Operating Income | -17.86M | -29.63M | -25.99M | 10.63M | -37.08M | -51.53M | -62.36M | -106.41M | -123.57M | 135.18M | -55.39M | -54.89M | -45.73M | -45.26M | -39.9M | -48.44M | -48.7M | -46.3M |
Interest Income | 386K | 309K | 2.17M | 129K | 1.03M | 451K | 1.49M | 3.52M | 2.8M | 3.29M | 3.68M | 1.77M | n/a | n/a | 2.34M | n/a | n/a | n/a |
Pretax Income | -19.96M | -30.48M | -23.82M | 10.76M | -36.05M | -48.99M | -60.57M | -102.89M | -120.77M | 21.33M | -51.71M | -53.13M | -43.09M | -43.92M | -37.56M | -47.6M | -47.15M | -45.68M |
Net Income | -19.99M | -30.6M | -23.4M | 10.67M | -36.13M | -49.09M | -60.3M | -104.16M | -114.51M | 21.13M | -51.97M | -53.16M | -43.17M | -43.98M | -37.5M | -47.69M | -47.17M | -45.93M |
Selling & General & Admin | 9.08M | 10.06M | 9.87M | 11.05M | 12.04M | 11.77M | 13.1M | 13.92M | 16.01M | 18.14M | 16.44M | 16.24M | 15.09M | 14.91M | 16.08M | 14.5M | 16.49M | 16.15M |
Research & Development | 27.08M | 26.01M | 23.68M | 27.73M | 24.22M | 35.89M | 50.71M | 57.09M | 63.05M | 63.22M | 66.18M | 65.12M | 60.02M | 58.58M | 51.8M | 62.5M | 60.09M | 56.43M |
Other Expenses | n/a | n/a | n/a | n/a | -23.05M | 28.57M | -2.38M | -12.29M | 51.35M | 58.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 36.16M | 36.06M | 33.54M | 38.78M | 13.22M | 76.23M | 61.42M | 58.72M | 79.06M | 81.35M | 82.62M | 81.35M | 75.11M | 73.49M | 67.89M | 77M | 76.57M | 72.58M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 113.85M | n/a | n/a | 2.64M | 1.34M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.16M | 36.06M | 33.54M | 40.96M | 37.44M | 52.01M | 64.41M | 115.81M | 79.06M | 81.35M | 82.62M | 81.35M | 75.11M | 73.49M | 67.89M | 77M | 76.57M | 72.58M |
Income Tax Expense | 27K | 119K | -427K | 88K | 74K | 98K | -272K | 1.27M | -6.26M | 194K | 259K | 30K | 82K | 58K | -67K | 86K | 24K | 262K |
Shares Outstanding (Basic) | 256.95M | 220.27M | 210.19M | 208.34M | 203.95M | 180.34M | 177.62M | 177.17M | 174.32M | 168.53M | 164.72M | 156.34M | 148.16M | 146.22M | 145.74M | 145.4M | 143.98M | 143.11M |
Shares Outstanding (Diluted) | 256.95M | 220.27M | 210.19M | 214.32M | 203.95M | 180.34M | 177.62M | 177.17M | 174.32M | 169.18M | 164.72M | 158.04M | 148.16M | 146.22M | 145.74M | 145.4M | 143.98M | 143.11M |
EPS (Basic) | -0.08 | -0.14 | -0.11 | 0.04 | -0.18 | -0.27 | -0.34 | -0.59 | -0.66 | 0.13 | -0.32 | -0.34 | -0.29 | -0.3 | -0.26 | -0.33 | -0.33 | -0.32 |
EPS (Diluted) | -0.08 | -0.14 | -0.11 | 0.04 | -0.18 | -0.27 | -0.34 | -0.59 | -0.66 | 0.12 | -0.32 | -0.34 | -0.29 | -0.3 | -0.26 | -0.33 | -0.33 | -0.32 |
EBITDA | -18.06M | -27.7M | -23.86M | 12.76M | -33.34M | -44.65M | -57.59M | -56.12M | -66.04M | 24.82M | -52.05M | -51.84M | -42.85M | -42.43M | -37.13M | -45.88M | -46.45M | -44.43M |
EBIT | -19.96M | -29.63M | -25.99M | 10.63M | -35.91M | -47.18M | -60.57M | -61.61M | -72.22M | 76.61M | -55.39M | -54.89M | -45.73M | -45.26M | -39.9M | -48.44M | -48.7M | -46.3M |
Depreciation & Amortization | 1.9M | 1.92M | 2.13M | 2.13M | 2.57M | 2.53M | 2.98M | 5.49M | 4.26M | 3.49M | 3.34M | 3.05M | 2.88M | 2.83M | 2.76M | 2.56M | 2.25M | 1.88M |